[HTML][HTML] Mechanisms of SARS-CoV-2 entry into cells

CB Jackson, M Farzan, B Chen, H Choe - Nature reviews Molecular …, 2022 - nature.com
The unprecedented public health and economic impact of the COVID-19 pandemic caused
by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been …

The role of Th17 response in COVID-19

D Martonik, A Parfieniuk-Kowerda, M Rogalska… - Cells, 2021 - mdpi.com
COVID-19 is an acute infectious disease of the respiratory system caused by infection with
the SARS-CoV-2 virus (Severe Acute Respiratory Syndrome Coronavirus 2). Transmission …

Obesity as a risk factor for severe COVID-19 and complications: a review

F Demeulemeester, K de Punder, M van Heijningen… - Cells, 2021 - mdpi.com
Emerging data suggest that obesity is a major risk factor for the progression of major
complications such as acute respiratory distress syndrome (ARDS), cytokine storm and …

COVID-19 and hypertension: the what, the why, and the how

SA Muhamad, A Ugusman, J Kumar, D Skiba… - Frontiers in …, 2021 - frontiersin.org
It has been a year since the coronavirus disease 2019 (COVID-19) was declared pandemic
and wreak havoc worldwide. Despite meticulous research has been done in this period …

Angiotensin II type I receptor (AT1R): the gate towards COVID-19-associated diseases

G El-Arif, S Khazaal, A Farhat, J Harb, C Annweiler… - Molecules, 2022 - mdpi.com
The binding of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike
glycoprotein to its cellular receptor, the angiotensin-converting enzyme 2 (ACE2), causes its …

SNPs of ACE1 (rs4343) and ACE2 (rs2285666) genes are linked to SARS-CoV-2 infection but not with the severity of disease

N Alimoradi, M Sharqi, D Firouzabadi, MM Sadeghi… - Virology Journal, 2022 - Springer
COVID-19 and the renin-angiotensin system (RAS) are linked by angiotensin-converting
enzyme 2 (ACE2), a key enzyme in RAS that has been validated as a SARS-CoV-2 receptor …

Immune response and molecular mechanisms of cardiovascular adverse effects of spike proteins from SARS-CoV-2 and mRNA vaccines

P Bellavite, A Ferraresi, C Isidoro - Biomedicines, 2023 - mdpi.com
The SARS-CoV-2 (severe acute respiratory syndrome coronavirus responsible for the
COVID-19 disease) uses the Spike proteins of its envelope for infecting target cells …

Risk factors for mortality in COVID-19 patients in sub-Saharan Africa: A systematic review and meta-analysis

B Bepouka, N Mayasi, M Mandina, M Longokolo… - PLoS …, 2022 - journals.plos.org
Aim Mortality rates of coronavirus-2019 (COVID-19) disease continue to increase worldwide
and in Africa. In this study, we aimed to summarize the available results on the association …

Role of angiotensin II in cardiovascular diseases: Introducing bisartans as a novel therapy for coronavirus 2019

J Swiderski, LK Gadanec, V Apostolopoulos, GJ Moore… - Biomolecules, 2023 - mdpi.com
Cardiovascular diseases (CVDs) are the main contributors to global morbidity and mortality.
Major pathogenic phenotypes of CVDs include the development of endothelial dysfunction …

[PDF][PDF] COVID-19: from the structure and replication cycle of SARS-CoV-2 to its disease symptoms and treatment.

JB Zawilska, A Lagodzinski… - Journal of Physiology & …, 2021 - academia.edu
In December 2019, a small number of cases of pneumonia of unknown origin were
recognized in the city of Wuhan, China. Soon, the disease, whose etiological factor was …